| 1 |
任成山，王关嵩，钱桂生. 慢性阻塞性肺疾病的成因及其治疗的困惑与希望[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(2): 127-141.
|
| 2 |
Adeloye Davies, Chua Stephen, Lee Chinwei, et al. Global and regional estimates of COPD prevalence: Systematic review and meta-analysis[J]. J Glob Health, 2015, 5(2): 020415.
|
| 3 |
World Health Organization. Projections of mortality and causes of death, 2016 and 2060. accessed 14 October 2019).
URL
|
| 4 |
Kim JH, Jo CH, Kim HR, et al. Comparison of immunological characteristics of mesenchymal stem cells from the periodontal ligament, umbilical cord, and adipose tissue[J]. Stem cells Int, 2018, 2018: 8429042.
|
| 5 |
秦秀军，张 伟，李建国，等. 人脂肪间充质干细胞的致瘤性研究[J]. 天津医药，2013, 41(2): 152-153+194.
|
| 6 |
许键炜，何志旭，舒莉萍，等. 人脐带间充质干细胞致瘤性试验[J]. 贵阳医学学报，2015, 40(1): 17-19+23.
|
| 7 |
Presti RM, Flores SC, Palmer BE, et al. Mechanisms underlying HIV-associated noninfectious lung disease[J]. Chest, 2017, 152(5): 1053-1060.
|
| 8 |
白春昀，翁稚颖，肖 创，等. 慢性阻塞性肺病相关炎症细胞及因子的研究进展[J]. 慢性病学杂志，2019, 15(1): 42-46.
|
| 9 |
de Witte Samantha FH, Luk Franka, Sierra Parraga Jesus M, et al. Immunomodulation by therapeutic mesenchymal stromal cells (MSC) is triggered through phagocytosis of MSC by monocytic cells[J]. Stem Cells, 2018 , 36(4): 602-615.
|
| 10 |
Ortiz LA, Dutreil M, Fattman C, et al. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury[J]. Proc Natl Acad Sci U S A, 2007,104(26): 11002-11007.
|
| 11 |
Gu W, Song L, Li XM, et al. Mesenchymal stem cells alleviate airway inflammation and emphysema in COPD through down-regulation of cyclooxygenase-2 via p38 and ERK MAPK pathways[J]. Sci Rep, 2015, 5: 8733.
|
| 12 |
Liu HM, Liu YT, Zhang J, et al. Bone marrow mesenchymal stem cells ameliorate lung injury through anti-inflammatory and antibacterial effect in COPD mice[J]. J Huazhong Univ Sci Technolog Med Sci, 2017, 37(4): 496-504.
|
| 13 |
Peron JPS, de Brito AA, Pelatti M, et al. Human tubal-derived mesenchymal stromal cells associated with low level laser therapy significantly reduces cigarette smoke-induced COPD in C57BL/6 mice [J]. PLoS One, 2015, 10(8): e0136942.
|
| 14 |
Kennelly H, Mahon BP, English K. Human mesenchymal stromal cells exert HGF dependent cytoprotective effects in a human relevant pre-clinical model of COPD[J]. Sci Rep, 2016, 6: 38207.
|
| 15 |
Yew TL, Hung YT, Li HY, et al. Enhancement of wound healing by human multipotent stromal cell conditioned medium: the paracrine factors and p38 MAPK activation[J]. Cell Transplant, 2011, 20: 693-706.
|
| 16 |
Massagué J. The transforming growth factor-beta family[J]. Annu Rev Cell Biol, 1990, 6: 597-641.
|
| 17 |
Akram KM, Samad S, Spiteri MA, et al. Mesenchymal stem cells promote alveolar epithelial cell wound repair in vitro through distinct migratory and paracrine mechanisms[J]. Respir Res, 2013, 14(1): 9.
|
| 18 |
Weiss DJ, Casaburi R, Flannery R, et al. A placebo-controlled, randomized trial of mesenchymal stem cells in COPD[J]. Chest, 2013, 143(6): 1590-1598.
|
| 19 |
Stolk J, Broekman W, Mauad T, et al. A phase I study for intravenous autologous mesenchymal stromal cell administration to patients with severe emphysema[J]. QJM, 2016, 109(5): 331-336.
|
| 20 |
Le Thi Bich P, Nguyen Thi H, Dang Ngo Chau H, et al. Allogeneic umbilical cord-derived mesenchymal stem cell transplantation for treating chronic obstructive pulmonary disease: a pilot clinical study[J]. Stem Cell Res Ther, 2020, 11(1): 60.
|